Holdings of VIFAG 2002, SICAV S.A.
GESALCALA, S.A., S.G.I.I.C. · Original filing · Compare with another fund · Report an error
- Net assets
- 82.6M € including 81.9M € in equities, 99.2 %
- Positions
- 134 in 16 countries
- Top ten
- 53.7 % of net assets
- Filed on
- Dec 31, 2025
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Block Inc | 110.8K € | 0.13 % | |
| 102 | Okta Inc | 110.4K € | 0.13 % | |
| 103 | Dell Technologies Inc | 107.1K € | 0.13 % | |
| 104 | Recursion Pharmaceuticals Inc | 104.4K € | 0.13 % | |
| 105 | Carbios SACA | 101.5K € | 0.12 % | |
| 106 | Aardvark Therapeutics Inc | 100.5K € | 0.12 % | |
| 107 | Figma Inc | 95.4K € | 0.12 % | |
| 108 | Aura Biosciences Inc | 92.8K € | 0.11 % | |
| 109 | Tenaya Therapeutics Inc | 90.5K € | 0.11 % | |
| 110 | Sirius XM Holdings Inc | 85.1K € | 0.10 % | |
| 111 | QUALCOMM Inc | 72.8K € | 0.09 % | |
| 112 | Equinix Inc | 65.2K € | 0.08 % | |
| 113 | Xinyi Solar Holdings Ltd | 65K € | 0.08 % | |
| 114 | INFLARX NV | 64.5K € | 0.08 % | |
| 115 | IMMUNIC INC | 59K € | 0.07 % | |
| 116 | RALLYBIO | 58.4K € | 0.07 % | |
| 117 | Evolus Inc | 56.6K € | 0.07 % | |
| 118 | Eledon Pharmaceuticals Inc | 56.1K € | 0.07 % | |
| 119 | Vor BioPharma Inc | 55.7K € | 0.07 % | |
| 120 | Meituan | 37.3K € | 0.05 % | |
| 121 | C4 Therapeutics Inc | 32.5K € | 0.04 % | |
| 122 | Rocket Pharmaceuticals Inc | 29.9K € | 0.04 % | |
| 123 | JIANPU TECHNOLOGIES INC | 27.7K € | 0.03 % | |
| 124 | Pliant Therapeutics Inc | 20.8K € | 0.03 % | |
| 125 | Adicet Bio Inc | 20.3K € | 0.02 % | |
| 126 | Largo Inc | 20.3K € | 0.02 % | |
| 127 | PURE ENERGY MINERALS LTD | 18.7K € | 0.02 % | |
| 128 | VISTAGEN THERAPEUTICS INC | 16.9K € | 0.02 % | |
| 129 | Plug Power Inc | 16.8K € | 0.02 % | |
| 130 | ADAGIO MEDICAL HOLDINGS INC | 15.3K € | 0.02 % | |
| 131 | Baozun Inc | 13.1K € | 0.02 % | |
| 132 | Enapter AG | 3.6K € | 0.00 % | |
| 133 | LUMINAR TECH | 68 € | 0.00 % | |
| 134 | RM2 INTERNATIONAL SA | 7 € |
Sector breakdown
- Technology 31.4 %
- Communication 20.9 %
- Consumer discretionary 7.9 %
- Industrials 0.4 %
- Health care 0.3 %
- Financials 0.3 %
- Energy 0.2 %
- Real estate 0.1 %
- Unattributed 38.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- EUR 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 83.2 %
- Taiwan 5.6 %
- Hong Kong SAR China 3.8 %
- Cayman Islands 3.0 %
- Canada 1.1 %
- Denmark 0.5 %
- South Korea 0.4 %
- Netherlands 0.4 %
- United Kingdom 0.4 %
- British Virgin Islands 0.4 %
- Ireland 0.3 %
- Switzerland 0.3 %
- Other countries 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 102 | 68.1M € | 83.16 % |
| 2 | Taiwan | 1 | 4.6M € | 5.63 % |
| 3 | Hong Kong SAR China | 6 | 3.1M € | 3.78 % |
| 4 | Cayman Islands | 5 | 2.5M € | 3.00 % |
| 5 | Canada | 5 | 915.5K € | 1.12 % |
| 6 | Denmark | 2 | 442.8K € | 0.54 % |
| 7 | South Korea | 2 | 368.3K € | 0.45 % |
| 8 | Netherlands | 2 | 344.5K € | 0.42 % |
| 9 | United Kingdom | 2 | 336K € | 0.41 % |
| 10 | British Virgin Islands | 1 | 288.2K € | 0.35 % |
| 11 | Ireland | 1 | 284.4K € | 0.35 % |
| 12 | Switzerland | 1 | 223.1K € | 0.27 % |
Cite this page
Titelia. "Holdings of VIFAG 2002, SICAV S.A.". https://titelia.com/en/funds/ESSICAV2628-0